共 50 条
- [1] Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialLANCET, 2013, 382 (9906): : 1705 - 1713Baeten, DominiqueBaraliakos, XenofonBraun, JuergenSieper, JoachimEmery, Paulvan der Heijde, DesireeMcInnes, Iainvan Laar, Jacob M.Landewe, RobertWordsworth, PaulWollenhaupt, JuergenKellner, HerbertParamarta, JacquelineWei, JiaweiBrachat, ArndtBek, StephanLaurent, DidierLi, YaliWang, Ying A.Bertolino, Arthur P.Gsteiger, SandroWright, Andrew M.Hueber, Wolfgang
- [2] Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET, 2015, 386 (9999): : 1137 - 1146McInnes, Iain B.Mease, Philip J.Kirkham, BruceKavanaugh, ArthurRitchlin, Christopher T.Rahman, ProtonVan der Heijde, DesireeLandewe, RobertConaghan, Philip G.Gottlieb, Alice B.Richards, HannoPricop, LuminitaLigozio, GregoryPatekar, ManmathMpofu, Shephard
- [3] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled TrialINDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 27 - 34Harish, B., VSahoo, Rasmi RanjanGochhait, SamanyoyaPatro, Pradeepta Sekhar
- [4] Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitisANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 397 - 397Van Denderen, JCVan der Paardt, MNurmohamed, MTDe Ryck, YMDijkmans, BACVan der Horst-Bruinsma, IE
- [5] A randomized, double-blind, placebo-controlled trial of (Enbrel®) in the treatment of Ankylosing Spondylitis.ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90Gorman, JDSack, KEDavis, JC
- [6] Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled studyANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1004 - 1013Deodhar, AtulSliwinska-Stanczyk, PaulaXu, HujiBaraliakos, XenofonGensler, Lianne S.Fleishaker, DonaWang, LisyWu, JosephMenon, SujathaWang, CunshanDina, OluwaseyiFallon, LaraKanik, Keith S.van der Heijde, Desiree
- [7] Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialGUT, 2012, 61 (12) : 1693 - 1700Hueber, WolfgangSands, Bruce E.Lewitzky, SteveVandemeulebroecke, MarcReinisch, WalterHiggins, Peter D. R.Wehkamp, JanFeagan, Brian G.Yao, Michael D.Karczewski, MarekKarczewski, JacekPezous, NicoleBek, StephanBruin, GerardMellgard, BjoernBerger, ClaudiaLondei, MarcoBertolino, Arthur P.Tougas, GervaisTravis, Simon P. L.
- [8] A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing SpondylitisJOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1203 - 1210Inman, Robert D.Maksymowych, Walter P.
- [9] Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialGUT, 2010, 59 (01) : 21 - 30Straumann, A.Conus, S.Grzonka, P.Kita, H.Kephart, G.Bussmann, C.Beglinger, C.Smith, D. A.Patel, J.Byrne, M.Simon, H-U
- [10] Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (02) : 349 - 356McInnes, Iain B.Sieper, JoachimBraun, JuergenEmery, Paulvan der Heijde, DesireeIsaacs, John D.Dahmen, GeorgWollenhaupt, JuergenSchulze-Koops, HendrikKogan, JosephMa, ShenglinSchumacher, Martin M.Bertolino, Arthur P.Hueber, WolfgangTak, Paul P.